Status:
COMPLETED
Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease
Lead Sponsor:
Columbia University
Conditions:
Celiac Disease
Eligibility:
All Genders
13-65 years
Phase:
NA
Brief Summary
The current treatment for celiac disease is a strict 100% gluten free diet. Little is known about the best way to promote adherence to such a strict diet and how to maximize quality of life at the sam...
Detailed Description
Little is known about the best ways to promote a strict gluten-free diet while maximizing quality of life in teenagers and adults with celiac disease. The aim of the proposed pilot is to assess the ac...
Eligibility Criteria
Inclusion
- Individuals \>13 years old (15 teenagers and 15 adults), 30 in total with duodenal biopsy-confirmed diagnosis of celiac disease will be recruited to participate.
- As we are testing a gluten sensor device, we require that participants are 13 years or older as they will need to be able to operate the gluten sensor device independently
Exclusion
- No participants will be excluded based on gender, race or ethnicity.
- Patients diagnosed with celiac disease without a duodenal biopsy.
Key Trial Info
Start Date :
January 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03321214
Start Date
January 2 2018
End Date
October 31 2018
Last Update
January 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Celiac Disease Center at Columbia University
New York, New York, United States, 10032